Matches in Nanopublications for { ?s ?p "[Correlation of ITIH5 expression with clinical outcome revealed that patients with primary tumours retaining abundant ITIH5 expression had longer recurrence-free survival (RFS; P=0.037) and overall survival (OS; P=0.044), compared to those with reduced expression (mean RFS: 102 vs 78 months; mean OS: 120 vs 105 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP494100.RA9YylCAIXmVpxNePFlZ6XNrquUMX-pCo5Fk94csW0IzM130_assertion description "[Correlation of ITIH5 expression with clinical outcome revealed that patients with primary tumours retaining abundant ITIH5 expression had longer recurrence-free survival (RFS; P=0.037) and overall survival (OS; P=0.044), compared to those with reduced expression (mean RFS: 102 vs 78 months; mean OS: 120 vs 105 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP494100.RA9YylCAIXmVpxNePFlZ6XNrquUMX-pCo5Fk94csW0IzM130_provenance.
- NP949868.RAbWjt1loAJ25TC_k7Hpr0klJgCo3CtU4FyoD5DfuwDGo130_assertion description "[Correlation of ITIH5 expression with clinical outcome revealed that patients with primary tumours retaining abundant ITIH5 expression had longer recurrence-free survival (RFS; P=0.037) and overall survival (OS; P=0.044), compared to those with reduced expression (mean RFS: 102 vs 78 months; mean OS: 120 vs 105 months).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP949868.RAbWjt1loAJ25TC_k7Hpr0klJgCo3CtU4FyoD5DfuwDGo130_provenance.